Somatic mutations affecting ETV6 often occur in acute lymphoblastic leukemia (ALL), the most common childhood malignancy. The genetic factors that predispose to ALL remain poorly understood. Here we identify a novel germline ETV6 p. L349P mutation in a kindred affected by thrombocytopenia and ALL. A second ETV6 p. N385fs mutation was identified in an unrelated kindred characterized by thrombocytopenia, ALL and secondary myelodysplasia/acute myeloid leukemia. Leukemic cells from the proband in the second kindred showed deletion of wild type ETV6 with retention of the ETV6 p. N385fs. Enforced expression of the ETV6 mutants revealed normal transcript and protein levels, but impaired nuclear localization. Accordingly, these mutants exhibited significantly reduced ability to regulate the transcription of ETV6 target genes. Our findings highlight a novel role for ETV6 in leukemia predisposition.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477877 | PMC |
| http://dx.doi.org/10.1371/journal.pgen.1005262 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
WBP1L regulates hematopoietic stem cell function and T cell development.
Front Immunol
November 2024
Laboratory of Leukocyte Signalling, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia.
Article Synopsis
- WBP1L (also known as OPAL1) is a protein linked to better outcomes in childhood leukemia and is involved in regulating hematopoiesis and CXCR4 signaling.
- Mice lacking WBP1L show dysregulated hematopoiesis, with enlarged thymi and increased thymocyte counts, likely due to the enhancement of multipotent progenitors in the bone marrow.
- The study highlights WBP1L's role in maintaining hematopoietic stem cell functionality, influencing leukocyte progenitor growth, and improving outcomes during stem cell transplants.
Genome-first determination of the prevalence and penetrance of eight germline myeloid malignancy predisposition genes: a study of two population-based cohorts.
Leukemia
November 2024
Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Article Synopsis
- About 10% of people with myeloid malignancies have a genetic predisposition, and a study used a genome-first approach to investigate this.
- They analyzed eight specific genes associated with myeloid malignancy risk in a large sample of individuals from two databases, discovering high odds of developing these cancers and reduced survival rates among those with harmful genetic variants.
- The most frequently found variant was in the DDX41 gene, which dramatically increased the likelihood of developing myeloid malignancies and also raised the risk of overall mortality among those affected.
Genetic predisposition to myelodysplastic syndrome: Genetic counseling and transplant implications.
Semin Hematol
December 2024
Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD.
Article Synopsis
- * It discusses hereditary conditions affecting platelet production, highlighting genes such as RUNX1, ETV6, and ANKRD26, and explores various genetic syndromes connected to MDS, like GATA2 deficiency and Fanconi anemia.
- * The importance of genetic counseling and personalized treatment options, including hematopoietic cell transplantation, is emphasized to enhance patient care and outcomes in MDS management.
Inherited Predispositions to Myeloid Neoplasms: Pathogenesis and Clinical Implications.
Annu Rev Pathol
October 2024
Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA; email:
Article Synopsis
- Myeloid neoplasms are diseases that affect blood cells and can happen with or without earlier platelet disorders.
- Certain genetic changes can make people more likely to develop these diseases, like acute myeloid leukemia and myelodysplastic syndrome.
- The World Health Organization now classifies these myeloid neoplasms linked to genetic issues as a special group, and the text discusses how to diagnose and manage these conditions.
Brain abscesses, neutropenia, and B-ALL: Multiple testing modalities required to confirm PDCD10 and ETV6 dual diagnoses.
Cancer Genet
November 2024
Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA; Department of Pathology, Texas Children's Hospital, Houston, TX, USA. Electronic address:
Recognition of patients with multiple diagnoses, and the unique challenges they pose to clinicians and laboratorians, is increasing rapidly as genome-wide genetic testing grows in prevalence. We describe a unique patient with dual diagnoses of PDCD10-related cerebral cavernous malformations and ETV6-related thrombocytopenia with associated neutropenia. She presented with brain abscesses as an infant, which is highly atypical for these disorders in isolation.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!